How to choose between them A simple way to think about the choice is this: Choose semaglutide if you want a more established option and are prioritising steady appetite control
The theoretical risk exists, but clinical evidence does not support increased incidence with semaglutide use
158 G-CSF, in contrast to GM-CSF, upregulates NAMPT, triggering NAD/SIRT1 granulopoiesis via C/EBP/ upregulation
Its copper also supports lysyl oxidase, the enzyme that cross-links new collagen fibers and gives the matrix strength (gene regulation, tissue clearing, and collagen cross-linking)
Treatment begins with 3 mg once daily for 30 days, which is a starter dose to improve tolerability and is not intended for glycaemic control
Concentration drops to 2.5 mg/mL